World-Leading Microsurgeon Professor J.P. Hong Joins MediThinQ as CMO, Marking Strong Validation for Next-Generation Digital Microsurgery

SINGAPORE, Dec. 3, 2025 /PRNewswire/ -- MediThinQ, a fast-growing innovator in surgical displays and digital

MediThinQ Enters China Through Strategic Partnership with Sinopharm, Making Wearable Surgical Displays a Reality in Operating Theatres

SINGAPORE, May 20, 2025 /PRNewswire/ -- MediThinQ, the South Korean company specialising in wearable extended

Qurient Co. Ltd. and TB Alliance Announce Exclusive License Agreement for Telacebec (Q203), a New Anti-Tuberculosis Agent

LIPS and Namuga Announce Strategic Alliance to Accelerate Global Commercialization of AI Machine Vision Solutions

TAIPEI and SEOUL, South Korea, Nov. 18, 2025 /PRNewswire/ -- LIPS Corporation, a global leader in 3D machine

ConcertAI's TeraRecon Expands Relationship with Change Healthcare for Advanced Visualization Offering in Australia

The expanded agreement allows providers to locally acquire TeraRecon's solutions CAMBRIDGE, Mass., July 24,

DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development

SEOUL, South Korea, Feb. 13, 2025 /PRNewswire/ -- DAAN Biotherapeutics, a leading innovative drug development

Alteogen Enters into a License Agreement with Biogen for Development and Commercialization of Hybrozyme™-Based Subcutaneous Biologics

- Biogen gains rights to develop and commercialize subcutaneous (SC) formulations for two products utilizing

Hansung ebusiness to Participate in Cosmobeauté Vietnam 2026, Accelerating K-Beauty Expansion in Southeast Asia

SEOUL, South Korea, Feb. 20, 2026 /PRNewswire/ -- Hansung ebusiness, a Korea-based K-beauty distribution and

NEXTBIOMEDICAL Secures Exclusive Distribution Agreement for Nexsphere-F™ in Japan

SEOUL, South Korea, April 9, 2026 /PRNewswire/ -- NEXTBIOMEDICAL CO., LTD. (KOSDAQ: 389650), an innovative